IMAT Solutions Named in Gartner® Hype Cycle™ for U.S. Healthcare Payers 2022 Report - IMAT Solutions
20495
page-template-default,page,page-id-20495,page-child,parent-pageid-88,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-7.5,wpb-js-composer js-comp-ver-6.1,vc_responsive

27 Jul IMAT Solutions Named in Gartner® Hype Cycle™ for U.S. Healthcare Payers, 2022 Report

 

July 27, 2022, Orem, UT – IMAT Solutions, a leader in delivering innovative, real-time, healthcare data management and population health reporting solutions, was recently named in the Gartner report: “Hype Cycle for U.S. Healthcare Payers, 2022.”

 

The Gartner Hype Cycle for U.S. Healthcare Payers, 2022 report provides critical input for strategic planning by tracking the maturity and adoption rates of payer technologies and deployment approaches. CIOs should use this to plan new and manage existing investments for business optimization and transformation.

 

IMAT Solutions is listed as a Sample Vendor in both the “Health Data Curation and Enrichment” and the “Clinical Data Integration” section of the report.
 

To learn more about how IMAT Solutions’ patented technology and comprehensive services transform volumes of data into actionable information – helping payers get the most out of their clinical and claims data – please click here.
 


 

Gartner, “Hype Cycle for U.S. Healthcare Payers, 2022 Report,”
Mandi Bishop and Connie Salgy, 15 July 2022

 

 


 

Gartner and Hype Cycle are registered trademarks and service marks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose, mark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.